ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
复制标题
DOI：
10.1136/esmoopen-2020-000820
复制
发表时间：
2020-05-01
期刊：
影响因子：
7.3
通讯作者：
Peters, Solange
中科院分区：
文献类型：
--
作者：
Passaro, Antonio;Addeo, Alfredo;Peters, Solange
COVID-19 大流行的特点是在 2020 年前几个月在全球范围内快速传播，促使制定了一套结构化的癌症护理管理建议，以维持尽可能高的标准。在此框架内，确保基本肿瘤服务不中断并保证最佳护理至关重要。这是一份针对肺癌管理的结构化提案，包括三个优先级，即：第 1 级（高优先级）、第 2 级（中优先级）和第 3 级（低优先级）——根据安大略省癌症护理、亨斯曼癌症研究所和临床效益量表的标准定义。该手稿强调了 COVID-19 大流行对肺癌护理的影响，并重新考虑了从诊断、分期和治疗的所有步骤。因此，这些建议应作为以下方面的指导：优先考虑癌症护理的不同方面，以减轻 COVID-19 大流行对患者管理可能产生的负面影响。随着形势的迅速发展，需要采取实际行动来保证患者得到最好的治疗，同时保护和尊重他们的权利、安全和福祉。在这种环境下，癌症从业者肩负着巨大的责任：提供及时、适当、富有同情心和合理的癌症护理，同时保护自己和患者免受 COVID-19 感染。在资源短缺的情况下，必须公平分配资源。因此，考虑到对卫生系统施加的可变限制，以下建议的应用可以有很大的细微差别，具体取决于其使用的时间和地点。癌症护理人员需要具有非凡的灵活性。
The COVID-19 pandemic, characterised by a fast and global spread during the first months of 2020, has prompted the development of a structured set of recommendations for cancer care management, to maintain the highest possible standards. Within this framework, it is crucial to ensure no disruption to essential oncological services and guarantee the optimal care. This is a structured proposal for the management of lung cancer, comprising three levels of priorities, namely: tier 1 (high priority), tier 2 (medium priority) and tier 3 (low priority)-defined according to the criteria of the Cancer Care Ontario, Huntsman Cancer Institute and Magnitude of Clinical Benefit Scale.The manuscript emphasises the impact of the COVID-19 pandemic on lung cancer care and reconsiders all steps from diagnosis, staging and treatment.These recommendations should, therefore, serve as guidance for prioritising the different aspects of cancer care to mitigate the possible negative impact of the COVID-19 pandemic on the management of our patients. As the situation is rapidly evolving, practical actions are required to guarantee the best patients' treatment while protecting and respecting their rights, safety and well-being. In this environment, cancer practitioners have great responsibilities: provide timely, appropriate, compassionate and justified cancer care, while protecting themselves and their patients from being infected with COVID-19. In case of shortages, resources must be distributed fairly. Consequently, the following recommendations can be applied with significant nuances, depending on the time and location for their use, considering variable constraints imposed to the health systems. An exceptional flexibility is required from cancer caregivers.